Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
RCM Provider VisiQuate Acquired by PE Firm Accel-KKR
VisiQuate announced on October 1 its acquisition by Menlo Park, California-based private equity firm Accel-KKR. Financial terms of the deal were not disclosed. VisiQuate offers a user-friendly end-to-end revenue cycle management (RCM) and analytics solution that lets virtually anyone in a healthcare organization explore complex data from multiple sources to quickly gain insights and create actionable workflows. Since it was founded in 2009, VisiQuate has partnered with hospitals and health systems to markedly improve their top and bottom line. The company is headquartered in Santa Rosa, California. Accel-KKR is a technology-focused investment firm with more than $5 billion in capital... Read More »
Spectra Medical Devices Acquires XL Precision Technologies
Spectra Medical Devices, a portfolio company of private equity firm QHP Capital, announced on September 30 that it entered into an agreement to acquire XL Precision Technologies. XL Precision Technologies is a contract development and manufacturing organization (CDMO) specializing in the manufacture of precision micro-components, complex tubular components and sub-assemblies for the medical device industry. It is based in Stockton-on-Tees, England. Spectra Medical Devices is one of the world’s leading manufacturers of made-to-spec procedural needles. Spectra is a CDMO to industry-leading, multi-national healthcare companies, global original equipment manufacturers and... Read More »
Valerio Therapeutics Acquires Emglev Therapeutics
On September 30, Valerio Therapeutics, a Paris-based, clinical-stage biotechnology company, announced its acquisition of Emglev Therapeutics. Founded in 2023, Emglev is a biotechnology company that was established as a spin-off of Institut Curie and aims to develop immunotherapies to address unmet medical needs in oncology. It is a single-domain antibody-based therapeutics company. It is headquartered in Paris, France. Valerio Therapeutics is focused on developing innovative oncology drugs targeting tumor DNA-binding functions through unique mechanisms of action in the sought-after field of DNA Damage Response. The company is focused on bringing early-stage... Read More »Healthcare M&A Activity in Q3 Stabilizes
Despite all the headwinds straining the healthcare M&A market, deal activity stabilized in the third quarter of 2024, according to preliminary results in the LevinPro HC database. With 489 deals on the books in the last week of September, we saw only a marginal decline in activity compared with the second quarter of 2024 and year-over-year numbers. From April to June, there were 499 deals, and in Q3:23, activity reached 516 deals. Disclosed spending followed a similar trend to quarterly deal volumes, which is not always the case. Announced prices hit approximately $44 billion in Q3:24, a 7% decline compared to the second quarter ($47.4 billion) but a 7% year-over-year increase... Read More »
Affinity Equity Partners Acquires Australian Diagnostic Imaging Provider for $658 Million
Hong Kong-based Affinity Equity Partners announced that it is acquiring radiology services provider Lumus Imaging from St Leonards, Australia-based healthcare company Healius Limited for A$965 million (approximately $658 million USD). Lumus Imaging is a Sydney, Australia-based diagnostic imaging company. It is made up of a team of radiographers, sonographers, nuclear medicine technologists and nurses. It has more than 2,000 diagnostic imaging experts and support staff across 135 sites across Australia. Affinity Equity Partners is one of the largest Asian private equity firms in the world, with more than $14 billion in assets under management. It was founded in 1998. Healius expects to net... Read More »
Sanner Group Expands Medical Device Offering With Gilero
Sanner Group, backed by London-based private equity firm GHO Capital, announced that it has acquired Gilero LLC. The addition of Gilero will enhance Sanner’s offering, positioning the business as a leading provider of end-to-end services across drug delivery, diagnostics and medtech device sectors. Gilero LLC is a medical device design, contract development manufacturing organization (CDMO) headquartered in the Durham, North Carolina suburb of Morrisville. Sanner Group is a leading global healthcare packaging manufacturer and medical device CDMO. Headquartered in Germany with manufacturing facilities across Germany, France, Hungary and China, Sanner has developed from a global market... Read More »
Winner Medical Acquires Global Resources International for $120 Million
On September 26, Winner Medical announced that it acquired 75.2% equity of Global Resources International, Inc. (GRI) for $120 Million. According to data captured in the LevinPro HC database, this acquisition marks the 23rd contract development manufacturing organization transaction of the year. Founded in 2000, GRI is a privately held corporation and a leading provider of comprehensive manufacturing and value-added services for medical devices, industrial products and protective solutions. Its products include surgical kits, drapes, sheets, containers, surgical gowns and industrial protective clothing. Winner Medical is a manufacturer of disposable wound-care and surgical products... Read More »
Molecular Designs Acquires Lamda Biotech
On September 25, Molecular Designs announced that it entered into an agreement to acquire Lamda Biotech. Lamda Biotech is a specialized provider of research products for application in molecular biology, functional genomics, proteomics and gene therapy. For more than 20 years, Lamda Biotech has been highly regarded for its offering of cutting-edge PCR products, RT-PCR reagents, RT-qPCR kits, Direct-PCR genotyping kits, DNA ladders, SafeStain and other protein and cell biology products. Molecular Designs is a team of doctors and scientists working to advance molecular diagnostics. It offers numerous multiplex PCR-based panels produced under GMP and ISO 13485:2016 quality... Read More »
